Within the first 6 months, there is a 9.65-fold increase in risk, and overall a 3.63-fold higher risk, when compared with the general population.27 In addition, patients with diabetes are more likely to develop TF following a CTR compared with patients without diabetes. This evidence concerns the gene TF and diabetes mellitus.